Literature DB >> 18345514

Mast cell inhibition and reduced ventricular arrhythmias in a swine model of acute myocardial infarction upon therapeutic administration of relaxin.

S Nistri1, L Cinci, A-M Perna, E Masini, D Bani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18345514     DOI： 10.1007/s00011-007-0602-6

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  5 in total

Review 1.  Heart Disease and Relaxin: New Actions for an Old Hormone.

Authors:  Teja Devarakonda; Fadi N Salloum
Journal:  Trends Endocrinol Metab       Date:  2018-03-08       Impact factor: 12.015

Review 2.  Relaxin: review of biology and potential role in treating heart failure.

Authors:  Sam L Teichman; Elaine Unemori; John R Teerlink; Gad Cotter; Marco Metra
Journal:  Curr Heart Fail Rep       Date:  2010-06

Review 3.  Anti-fibrotic actions of relaxin.

Authors:  C S Samuel; S G Royce; T D Hewitson; K M Denton; T E Cooney; R G Bennett
Journal:  Br J Pharmacol       Date:  2016-07-07       Impact factor: 8.739

4.  Effect of Relaxin Expressing Adenovirus on Scar Remodeling: A Preliminary Study.

Authors:  Bok Ki Jung; Won Jai Lee; Eunhye Kang; Hyo Min Ahn; Yong Oock Kim; Dong Kyun Rah; Chae-Ok Yun; In Sik Yun
Journal:  Arch Craniofac Surg       Date:  2017-03-25

Review 5.  Regulation of Type 2 Immunity in Myocardial Infarction.

Authors:  Jun-Yan Xu; Yu-Yan Xiong; Xiao-Tong Lu; Yue-Jin Yang
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.